- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03664817
Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Young black men who have sex with men (YBMSM) have high rates of HIV infection, and are also at risk for falling out of clinical care. Social capital, which refers to the resources in a person's social network, has been shown to be beneficial for people living with HIV in other places. The study wants to understand and build upon social capital in the YBMSM population in Atlanta, with the goal of ultimately improving HIV-related outcomes for these youth.
To achieve this study is conducted in 3 phases. In Phase I, study will conduct interviews with YBMSM and community leaders to get advice about developing a social capital intervention that will improve social capital. Phase II is a randomized controlled trial of groups of YBMSM implementing the social capital intervention versus groups of YBMSM receiving a general health promotion intervention (Health for Life; H4L). This is followed by Phase III which is mainly to measure the social capital and engagement in care with the HIV-positive YBMSM at 3 and 9 month timepoints.
The study plan to enroll 180 total participants (120 in the randomized controlled trial and 60 in preliminary interviews) over the four year study period.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Georgia
-
Atlanta, Georgia, Vereinigte Staaten, 30322
- Emory University 1518 Clifton Rd
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age <= 29 years and >= 18 years
- Self-identify as Black/African-American (inclusive of multiracial identities)
- Male sex at birth
- Endorse history of sex with men ever (inclusive of gay and bisexual men)
- HIV-positive (self-reported by participant and confirmed by medical record)
- Able and willing to provide written consent and participate in surveys, interviews, and/or group intervention
Exclusion Criteria:
- Age < 18 years or >= 30 years
- Unwilling or unable to provide written informed consent
- Enrollment in one phase of the study is an exclusion criteria for enrollment in other phases
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: social capital intervention
This group will receive intervention developed from Phase 1 study and based on photovoice project
|
The social capital intervention will focus on developing skills and group-work that culminate in participant-derived photovoice projects.
Each group of YBMSM will be encouraged to complete a 30 day photovoice challenge.
The 30 day challenge is based on a prior community action project done as a part of our Centers for AIDS Research (CFAR)-funded research, which was a Photovoice project conducted by Dr. Hussen.
Photovoice is a participatory action research methodology in which groups of individuals from a population of interest are given cameras to document events, people and places of significance in their lives.
|
Aktiver Komparator: group-based health promotion intervention
The intervention will be a modified version of "Health for Life" or H4L, which was used as a control arm intervention in a recently completed protocol of the Adolescent Trials Network which was co-chaired by Dr. Harper (University of Michigan)
|
The control arm will participate in a health education intervention that will be delivered in a group, but without a specific goal of creating group cohesion or social capital.
The intervention will be a modified version of "Health for Life" or H4L, which was used as a control arm intervention in a recently completed protocol of the Adolescent Trials Network which was co-chaired by Dr. Harper (University of Michigan).
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in Modified Social Capital Scale (MSCS) between the social capital intervention group and group-based health promotion intervention
Zeitfenster: Baseline, 4 months after beginning intervention, 10 months after beginning intervention
|
Modified Social Capital Scale (MSCS) is an In-Depth Interview Guide that asks questions about social capital and engagement in care.
The scale is recently modified, pilot tested, and validated Chen's Social Capital Scale.
The instrument contained 10 composite items based on 42 items for assessing personally owned social capital, including bonding and bridging capitals.
The questionnaire is a open ended questionnaire with probe questions.
The scale contains subscales for bonding and bridging capital, and it also contains items that specify sources (including family, friends, and lesbian, gay, bisexual, and transgender (LGBT) organizations) and types of support (e.g.
emotional support, instrumental support and informational support).
The data will be transcribed verbatim by a professional business transcription service.
Thematic analysis using a combination of inductive and deductive coding will be conducted to analyze the score.
|
Baseline, 4 months after beginning intervention, 10 months after beginning intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in viral load suppression measured as copies/ml at baseline, post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Zeitfenster: Baseline, 4 months and 10 months
|
Viral load values will be extracted from the participants' electronic medical records (EMR).
Viral load refers to the number of viral particles found in each millilitre of blood.
Viral load tests measure the amount of HIV's genetic material in a blood sample.
The results of a viral load test are described as the number of copies of HIV RNA in a millilitre of blood.
The viral load test should consistently detect and measure virus levels down to 50 copies/mL, have a high specificity and provide reproducible results.
The technologies used are advanced and very sensitive for measuring the amount of HIV genetic material present in the blood.
|
Baseline, 4 months and 10 months
|
Change in number of receiving two or more cluster of differentiation 4 (CD4) tests at baseline, post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Zeitfenster: Up to 10 months
|
Retention in Care will be measured by determining receiving two or more cluster of differentiation 4 (CD4) tests.
This information will be gathered from subject's electronic medical record
|
Up to 10 months
|
Number of HIV visits at baseline, post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Zeitfenster: Up to 10 months
|
Retention in Care will be measured by determining participation in continuous care, that is, at least two or more routine HIV visits at least three months apart.
This information will be gathered from subject's electronic medical record
|
Up to 10 months
|
Change in subjects self report to question at baseline, post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Zeitfenster: Baseline and 10 months
|
Adherence to antiretroviral medications will be measured using a composite of single item self-report question and pharmacy refill records that will be conducted and evaluated at baseline and at 9 months.
|
Baseline and 10 months
|
Number of viral load tests at post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Zeitfenster: Up to 10 months
|
Retention in Care will be measured by determining receiving two or more viral load tests.
This information will be gathered from subject's electronic medical record.
|
Up to 10 months
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Sophia Hussen, M.D., M.P.H., Emory University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- RNA-Virusinfektionen
- Viruserkrankungen
- Infektionen
- Durch Blut übertragene Infektionen
- Übertragbare Krankheiten
- Sexuell übertragbare Krankheiten, viral
- Sexuell übertragbare Krankheiten
- Lentivirus-Infektionen
- Retroviridae-Infektionen
- Immunologische Mangelsyndrome
- Erkrankungen des Immunsystems
- HIV-Infektionen
Andere Studien-ID-Nummern
- IRB00088255
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur HIV-Infektionen
-
Duke UniversityAbgeschlossenCentral Line-associated Bloodstream Infection (CLABSI)Vereinigte Staaten
-
Catholic University of the Sacred HeartAbgeschlossenCentral Line-associated Bloodstream Infection (CLABSI)
-
Abbott Medical DevicesThoratec CorporationAbgeschlossenDriveline Heart-assisted Device Related InfectionVereinigte Staaten
-
Princess Maxima Center for Pediatric OncologyUMC Utrecht; Dutch Cancer SocietyRekrutierungCentral Line-associated Bloodstream Infection (CLABSI)Niederlande
-
University of MalayaTeleflexRekrutierungCLABSI – Central Line Associated Bloodstream InfectionMalaysia
-
National Taiwan University Hospital Hsin-Chu BranchAbgeschlossenCentral Line-associated Bloodstream Infection (CLABSI)
-
Johns Hopkins UniversityAbgeschlossenCLABSI – Central Line Associated Bloodstream InfectionVereinigte Staaten
-
National Taiwan University HospitalAbgeschlossenCentral Line-associated Bloodstream Infection (CLABSI)Taiwan
-
University of ZurichNoch keine RekrutierungCentral Line-associated Bloodstream Infection (CLABSI) | Katheterbedingte Blutstrominfektion
-
Princess Anna Mazowiecka Hospital, Warsaw, PolandNutricia FoundationAktiv, nicht rekrutierendWachstumsfehler | CLABSI – Central Line Associated Bloodstream InfectionPolen
Klinische Studien zur social capital intervention
-
Unity Health TorontoCovenant House Toronto; The Resource Association for Teens (RAFT); StepStones... und andere MitarbeiterAktiv, nicht rekrutierend
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; The Oscar G. & Elsa S. Mayer Family FoundationAbgeschlossenPostpartale Depression | ErziehungVereinigte Staaten
-
University of California, IrvineUniversity of California, Los AngelesAbgeschlossenHIVVereinigte Staaten
-
University of California, Los AngelesBrown University; Asociación Civil Impacta Salud y Educación, Peru; The Fenway...Abgeschlossen
-
Tel Aviv UniversityMinistry for Senior Citizens, IsraelAbgeschlossen
-
The University of Hong KongLok Sin Tong Benevolent Society, KowloonAbgeschlossen
-
Emory UniversityNational Institute of Mental Health (NIMH); University of KwaZuluAbgeschlossenHIV-1-Infektion | Heranwachsendes VerhaltenSüdafrika
-
University of California, San FranciscoHopeLab Foundation; Tobacco Related Disease Research Program; Rescue AgencyAktiv, nicht rekrutierendDampfenVereinigte Staaten
-
University of BelgradeAbgeschlossenPhysische AktivitätSerbien
-
University of PennsylvaniaUniversity of California, Berkeley; University of California, Davis; University...Aktiv, nicht rekrutierendHerzkrankheiten | Covid19 | ImpfverweigerungVereinigte Staaten